NCT01837485View on ClinicalTrials.gov

Probiotics in the Treatment of Irritable Bowel Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Lactol

The Symbiotic Lactol® (Bioplus Life Sciences Pvt.) was applied 3 times a day for 3 months. Lactol is composed of the followings; Lactobacillus Sporogenes (15 × 107 Spores), Fructo-Oligosaccharides, Microcrystalline Cellulose, Sodium starch Glycolate, Povidone, Hypermellose Stearate, Sillicon Dioxide, and Propylene Glycol.

DRUG

Placebo

Placebo pill was applied 3 times a day for 3 months

Trial Locations (1)

Unknown

Shariati Hospital, Isfahan

All Listed Sponsors
lead

Islamic Azad University, Najafabad Branch

OTHER

NCT01837485 - Probiotics in the Treatment of Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter